Pharma & Biopharma

Small-molecule inhibition of the SARS-CoV-2 viral protease may represent a promising route for therapy

Could NMR analysis of the SARS-CoV-2 envelope protein allow us to identify small-molecule inhibitors to fight COVID-19?

Charge-detection MS is apt for analyzing huge molecules - could it help in the fight against COVID-19?

Introducing the 3D crystal structure of the main Sars-CoV-2 protease

An expert panel outline their top literature picks from 2019

Complex biologic characterization demands a new era of instrumentation assay technology – the analytical community must seize the opportunity.

Illuminating antiretroviral accumulation in the brain using LC-MS and MALDI-MSI - the key to tackling HIV-associated neurocognitive disorder?

Tomasz Walski, Project Group Leader in the R&D department at Mabion S.A., tells us how he is keeping glycan analysis short and sweet.

How can analytical chemistry support the rise of organoids and organ-on-a-chip technologies?

2D-LC-MS brings important benefits to the fields of pharma, biopharma, omics, and natural product analysis.